Crewe Advisors LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Crewe Advisors LLC

  • $888 Million
  • Q2 2024

A detailed history of Crewe Advisors LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Crewe Advisors LLC holds 150 shares of XBI stock, worth $14,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Previous 150 -0.0%
Holding current value
$14,761
Previous $14,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$87.05 - $102.89 $13,057 - $15,433
150 New
150 $14,000
Q4 2020

Jan 27, 2021
BUY
$110.36 - $151.14 $6,731 - $9,219
61 Added 321.05%
80 $11,000
Q3 2020

Oct 13, 2020
BUY
$103.87 - $120.36 $1,973 - $2,286
19 New
19 $2,000
Q2 2019

Aug 09, 2019
SELL
N/A
-34 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
N/A
-130 Reduced 79.27%
34 $3,000
Q4 2017

Feb 09, 2018
BUY
N/A
164
164 $14,000

Others Institutions Holding XBI

# of Institutions
893
Shares Held
94.5M
Call Options Held
18.4M
Put Options Held
31.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email